We deliver pioneering and cost-effective solutions for the global surgical market. Our ultrasound-based tools for intraoperative quality assessment reduce adverse events and re-interventions, and ultimately improve the patients´ quality of life.
Read more >>>
Subscribe to our Newsletter >>
Reduce risk of early graft failure, stroke, myocardial infarction or recurrent angina - and provide the highest quality of life for your patients
We are seeking new distribution partners >>
NICE has developed medical technology guidance on the VeriQ system for assessing graft flow during CABG
The company you have known for decades as providing the premier CABG quality assessment devices invites you to check out our latest offering at the STS/AATS Tech-Con 2012 and STS 48th Annual Meeting in Fort Lauderdale
A new transit time flow measurement (TTFM) probe line specifically designed for vascular surgery is being launched at the annual conference of the European Society for Vascular Surgery (ESVS)
Findings substantiate the VeriQ system’s ability to improve outcomes for coronary artery bypass surgery and contain costs.
“The VeriQ system is associated with an estimated cost saving of £115 per patient compared with clinical assessment, when it is used routinely for assessing coronary artery bypass grafts during surgery.”
A new transit time flow measurement (TTFM) probe line specifically designed for vascular surgery is being launched at the annual conference of the European Society for Vascular Surgery (ESVS).